INOZYME PHARMA, INC. Accounts Payable
INOZYME PHARMA, INC. had Accounts Payable of $3.67 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-05-14
- 2025-03-31: Accounts Payable, Current $3.67M.
- 2024-12-31: Accounts Payable, Current $2.53M.
- 2024-09-30: Accounts Payable, Current $2.21M.
- 2024-06-30: Accounts Payable, Current $3.53M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-03-31 | $3.67M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.53M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $2.21M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $3.53M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.17M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.17M 10-K · filed 2025-03-10 |
| 2023-09-30 | $2.01M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.01M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.81M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.54M 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.39M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.34M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.20M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.39M 10-K · filed 2023-03-22 |
| 2021-09-30 | $626.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $796.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.71M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $3.07M 10-K · filed 2022-03-15 |
| 2020-09-30 | $3.67M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.40M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $901.00K 10-K · filed 2021-03-25 |